Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
MaxCyte
MXCT
$130M
| $9.63M | ﹤0.01% |
2,474,632
+47,960
| +2% | +$202K |
|
|
KALV
2402
DELISTED
KalVista Pharmaceuticals
KALV
| $9.62M | ﹤0.01% |
830,984
+24,713
| +3% | +$311K |
|
2403
New Fortress Energy
NFE
$97.8M
| $9.62M | ﹤0.01% |
1,058,402
-164,633
| -13% | -$2.54M |
|
2404
NRC Health Common Stock
NRC
$462M
| $9.62M | ﹤0.01% |
420,733
+13,039
| +3% | +$295K |
|
2405
Methode Electronics
MEI
$581M
| $9.6M | ﹤0.01% |
802,728
+20,487
| +3% | +$229K |
|
2406
Ibotta
IBTA
$729M
| $9.59M | ﹤0.01% |
155,669
+2,019
| +1% | +$122K |
|
2407
Beyond Meat
BYND
$268M
| $9.59M | ﹤0.01% |
1,413,742
-1,635
| -0.1% | -$10.3K |
|
2408
EyePoint Inc
EYPT
$1.13B
| $9.58M | ﹤0.01% |
1,199,056
+166,699
| +16% | +$1.46M |
|
|
MOFG
2409
DELISTED
MidWestOne Financial Group
MOFG
| $9.58M | ﹤0.01% |
335,677
+9,787
| +3% | +$266K |
|
|
SPYM
2410
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
| – | – |
0
| – | – |
|
|
DFTX
2411
Definium Therapeutics
DFTX
$5.99B
| $9.55M | ﹤0.01% |
1,677,702
+162,933
| +11% | +$1.13M |
|
2412
Digimarc Corp
DMRC
$168M
| $9.54M | ﹤0.01% |
354,738
-2,217
| -0.6% | -$65.4K |
|
2413
Bally's
BALY
$637M
| $9.53M | ﹤0.01% |
552,560
-22,142
| -4% | -$355K |
|
2414
Alerus Financial
ALRS
$827M
| $9.52M | ﹤0.01% |
416,072
+15,966
| +4% | +$341K |
|
2415
Xeris Biopharma Holdings
XERS
$1.46B
| $9.5M | ﹤0.01% |
3,333,470
+93,091
| +3% | +$239K |
|
2416
iRadimed
IRMD
$1.15B
| $9.5M | ﹤0.01% |
188,893
-1,568
| -0.8% | -$72.3K |
|
|
SNBR
2417
DELISTED
Sleep Number
SNBR
| $9.49M | ﹤0.01% |
518,045
+18,182
| +4% | +$238K |
|
2418
Tejon Ranch
TRC
$445M
| $9.44M | ﹤0.01% |
537,987
+4,247
| +0.8% | +$75.4K |
|
|
TELL
2419
DELISTED
Tellurian Inc.
TELL
| $9.43M | ﹤0.01% |
9,741,164
+1,283,160
| +15% | +$1.11M |
|
2420
Compass Minerals
CMP
$1.13B
| $9.41M | ﹤0.01% |
782,811
+6,062
| +0.8% | +$64.2K |
|
|
PLYA
2421
DELISTED
Playa Hotels & Resorts
PLYA
| $9.4M | ﹤0.01% |
1,212,592
-50,624
| -4% | -$401K |
|
2422
Celcuity
CELC
$4.43B
| $9.4M | ﹤0.01% |
630,369
+136,518
| +28% | +$2.25M |
|
2423
World Acceptance Corp
WRLD
$871M
| $9.4M | ﹤0.01% |
79,620
-4,362
| -5% | -$525K |
|
|
CMRC
2424
Commerce.com Inc Series 1
CMRC
$175M
| $9.36M | ﹤0.01% |
1,600,219
+21,105
| +1% | +$139K |
|
2425
Birkenstock
BIRK
$7.3B
| $9.3M | ﹤0.01% |
188,714
+63,289
| +50% | +$3.44M |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.